PrNMI

CAS No. 1541244-33-0

PrNMI( —— )

Catalog No. M12180 CAS No. 1541244-33-0

PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 745 Get Quote
10MG 1017 Get Quote
25MG 1431 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PrNMI
  • Note
    Research use only, not for human use.
  • Brief Description
    PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist.
  • Description
    PrNMI is a peripherally restricted cannabinoid 1 receptor (CB1R) agonist, significantly alleviates spontaneous pain behaviors in the animals.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1541244-33-0
  • Formula Weight
    409.573
  • Molecular Formula
    C29H31NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    4-{2-[-(1E)-1[(4-propylnaphthalen-1-yl)methylidene]-1H-inden-3-yl]ethyl}morpholine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhang H, et al. Pain. 2018 May 16. doi: 10.1097/j.pain.0000000000001278.
molnova catalog
related products
  • XL-001

    XL-001 (XL001) is a novel specific CB2 inverse agonist with Ki of 0.5 nM.

  • GAT-211

    GAT-211 (GAT211) is a selective cannabinoid 1 receptor (CB1R) positive allosteric modulator with pKb of 7.26, Arrestin2 EC50 of 775 nM.

  • Drinabant

    Drinabant is an orally active CB1 receptor antagonist. Drinabant inhibits the agonist-stimulated calcium signal with IC50 values of 25 nM and 10 nM for the hCB1-R and rCB1-R, respectively, and is ineffective for the hCB2-R.